BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the best get-rich-quick stocks to buy according to hedge funds. On ...

Coriolis Pharma, a global contract research and development organization, celebrated the grand opening of its new North America headquarters and laboratory, marking the start of operations at the ...

An East Midlands biotech firm has secured a licensing agreement with global pharmaceutical company AbbVie for its genome editing technology. Forge Genetics has signed a deal granting AbbVie an ...

ImmunityBio's recently approved cancer drug has plenty of momentum. However, valuation concerns and clinical and regulatory ...

The stock looks like a great pick to help turn investors into multimillionaires, given enough time. Everyone should save ...

West Pharmaceutical Services, Inc. WST is well-positioned for growth, backed by strong demand for HVPs, expanding GLP-1 drug programs and regulatory-driven Annex 1 conversions. However, tariff impacts ...

As the pharmaceutical industry continues to evolve in the wake of pandemic-driven disruptions and heightened regulatory scrutiny, the role of the top pharmaceutical API manufacturer has taken on ...

In today's Pharmaceutical Executive Daily, a new West Health-Gallup survey finds that more than 82 million Americans have cut back on daily expenses to cover healthcare costs, the FDA expands the ...

Amid growing regulatory pressures, including IRA pricing reforms, RevSavvy reports increasing adoption of its ARC platform and consulting services to help pharmaceutical companies manage system ...

Third Avenue Management, a New York City-based investment firm, published its fourth-quarter 2025 investor letter for the “Third Avenue Small-Cap Value Fund. ” A copy of the letter is available for ...

In today's Pharmaceutical Executive Daily, Senate Democrats press major pharmaceutical companies for transparency on the terms of their most-favored-nation pricing deals with the Trump administration, ...